IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT

被引:27
|
作者
Rengerink, Katrien Oude [1 ]
Opmeer, Brent C. [2 ]
Logtenberg, Sabine L. M. [3 ]
Hooft, Lotty [4 ]
Bloemenkamp, Kitty W. M. [5 ]
Haak, Monique C. [6 ]
Oudijk, Martijn A. [7 ]
Spaanderman, Marc E. [8 ]
Duvekot, Johannes J. [9 ]
Willekes, Christine [10 ]
van Pampus, Maria G. [11 ]
Porath, Martina M. [12 ]
van Eyck, Jim [13 ]
Sikkema, Marko J. [14 ]
Mol, Ben Willem J. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands
[3] Onze Lieve Vrouw Hosp, Dept Obstet & Gynaecol, Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dutch Cochrane Ctr, NL-1105 AZ Amsterdam, Netherlands
[5] Leiden Univ, Dept Obstet, Med Ctr, Leiden, Netherlands
[6] Vrije Univ Amsterdam Med Ctr, Dept Obstet & Gynaecol, Amsterdam, Netherlands
[7] Univ Med Ctr Utrecht, Dept Obstet & Gynaecol, Utrecht, Netherlands
[8] Radboud Univ Nijmegen Med Ctr, Dept Obstet & Gynaecol, Nijmegen, Netherlands
[9] Erasmus Univ, Dept Obstet & Gynaecol, Med Ctr, Rotterdam, Netherlands
[10] Maastricht Univ Med Ctr, Dept Obstet & Gynaecol, Maastricht, Netherlands
[11] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, Groningen, Netherlands
[12] Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands
[13] Isala Klin, Dept Obstet & Gynaecol, Zwolle, Netherlands
[14] Hosp Grp, Dept Perinatol & Gynaecol, Twente, Almelo, Netherlands
关键词
BARRIERS; CANCER; ATTITUDES; ONCOLOGY;
D O I
10.1186/1471-2288-10-85
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: One of the most commonly reported problems of randomised trials is that recruitment is usually slower than expected. Trials will cost more and take longer, thus delaying the use of the results in clinical practice, and incomplete samples imply decreased statistical power and usefulness of its results. We aim to identify barriers and facilitators for successful patient recruitment at the level of the patient, the doctor and the hospital organization as well as the organization and design of trials over a broad range of studies. Methods/design: We will perform two cohort studies and a case-control study in the Netherlands. The first cohort study will report on a series of multicenter trials performed in a nationwide network of clinical trials in obstetrics and gynaecology. A questionnaire will be sent to all clinicians recruiting for these trials to identify determinants aggregated at centre level - for the recruitment rate. In a case control-study nested in this cohort we will interview patients who refused or consented participation to identify factors associated with patients' consent or refusal. In a second cohort study, we will study trials that were prospectively registered in the Netherlands Trial Register. Using a questionnaire survey we will assess whether issues on hospital organization, trial organization, planning and trial design were associated with successful recruitment, i.e. 80% of the predefined number of patients recruited within the planned time. Discussion: This study will provide insight in barriers and facilitators for successful patient recruitment in trials. The results will be used to provide recommendations and a checklist for individual trialists to identify potential pitfalls for recruitment and judge the feasibility prior to the start of the study. Identified barriers and motivators coupled to evidence-based interventions can improve recruitment of patients in clinical trials.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT
    Katrien Oude Rengerink
    Brent C Opmeer
    Sabine LM Logtenberg
    Lotty Hooft
    Kitty WM Bloemenkamp
    Monique C Haak
    Martijn A Oudijk
    Marc E Spaanderman
    Johannes J Duvekot
    Christine Willekes
    Maria G van Pampus
    Martina M Porath
    Jim van Eyck
    Marko J Sikkema
    Ben Willem J Mol
    [J]. BMC Medical Research Methodology, 10
  • [2] IMPROVING PARTICIPATION IN CLINICAL TRIALS
    Byrne, Margaret M.
    Studts, Jamie L.
    Politi, Mary
    Langford, Aisha
    Jacobsen, Paul
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2016, 50 : S210 - S210
  • [3] Upcoming TAVI trials: rationale, design and impact on clinical practice
    Capodanno, Davide
    Leon, Martin B.
    [J]. EUROINTERVENTION, 2016, 12 : Y51 - Y55
  • [4] Not a spectator sport: improving participation of Black patients in cardiovascular clinical trials
    LaPrincess C. Brewer
    Joshua J. Joseph
    [J]. Nature Reviews Cardiology, 2024, 21 : 67 - 68
  • [5] Not a spectator sport: improving participation of Black patients in cardiovascular clinical trials
    Brewer, LaPrincess C.
    Joseph, Joshua J.
    [J]. NATURE REVIEWS CARDIOLOGY, 2024, 21 (02) : 67 - 68
  • [6] Improving the design of clinical trials
    Polman, C. H.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S5 - S5
  • [7] Rationale and design of the enoximone clinical trials program
    Lowes, BD
    Shakar, SF
    Metra, M
    Feldman, AM
    Eichhorn, E
    Freytag, JW
    Gerber, MJ
    Liard, JF
    Hartman, C
    Gorczynski, R
    Evans, G
    Linseman, JV
    Stewart, J
    Robertson, AD
    Roecker, EB
    Demets, DL
    Bristow, MR
    [J]. JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : 659 - 669
  • [8] PRIOR PARTICIPATION IN CLINICAL TRIALS IN SCHIZOPHRENIA: DOES THE DESIGN OF THE CLINICAL TRIAL HAVE AN IMPACT?
    Randall, Penny
    Kalali, A.
    Jacobs, K.
    [J]. SCHIZOPHRENIA BULLETIN, 2009, 35 : 361 - 361
  • [9] Impact of the participation on clinical trials in the prognosis of acute coronary syndrome patients
    Monteiro, P. F.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 359 - 359
  • [10] Improving the Design of Pivotal Clinical Trials
    Prasad, Vinay K.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (03) : 150 - 152